Search for a report

GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

The global pharmaceutical continuous manufacturing market is projected to register a CAGR of 10.23% and is anticipated to generate a revenue of $935.0 million by 2028. The base year considered for the market study is 2020, while the forecast period is from 2021 to 2028. The pharmaceutical continuous manufacturing market growth is anticipated to be driven by the increased adoption of continuous manufacturing systems over the existing drug manufacturing processes, their growing awareness across developing regions, and technological advancements.

GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous System, Semi-continuous System, Control & Software) by Application (Final Drug Product Manufacturing, Api Manufacturing) by End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Other End-users) and by Geography

Request free sample

The global pharmaceutical continuous manufacturing market is projected to register a CAGR of 10.23% and is anticipated to generate a revenue of $935.0 million by 2028. The base year considered for the market study is 2020, while the forecast period is from 2021 to 2028.

The pharmaceutical continuous manufacturing market growth is anticipated to be driven by the increased adoption of continuous manufacturing systems over the existing drug manufacturing processes, their growing awareness across developing regions, and technological advancements.
pharmaceutical-continuous-manufacturing-market

To know more about this report, request a free sample copy

Key factors propelling the global pharmaceutical continuous manufacturing market growth:

  • Development opportunities in untapped emerging markets
  • Increased adoption of pharmaceutical continuous manufacturing systems
    • The adoption of continuous manufacturing systems has augmented the existing drug manufacturing processes, primarily due to the advantages they offer.
    • For instance, integrated continuous manufacturing does not involve manual handling, and increases occupational safety, curbs processing times, and enhances production efficiency.
  • Rising government initiatives for the adoption of continuous manufacturing systems
  • Rising production of large molecules and biologics
  • Surge in healthcare expenditure

Major restraining factors:

  • Increasing customer anticipations
  • Lack of demand for continuous manufacturing systems in underdeveloped countries
    • The low spending power of customers is a major constraint, thereby making the production of higher quality drugs difficult for the pharmaceutical industry.

The report scope of the global pharmaceutical continuous manufacturing market includes the segmentation analysis of product, application, and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Product:

  • Integrated Continuous System
    • The integrated continuous system segment is set to lead the product category.
    • Integrated continuous systems are used to provide pharmaceutical products with superior quality, improved yield, and reduced cost, within a shorter time period.
    • Moreover, support by the regulatory authorities for the adoption of continuous manufacturing positively influences the market growth.
  • Control & Software
  • Semi-Continuous System

Geographically, the global pharmaceutical continuous manufacturing market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2020.
    • The region’s pharmaceutical continuous manufacturing market is anticipated to exhibit constant growth, majorly due to the presence of well-developed infrastructure in pharmaceutical industries, along with the surging use of continuous manufacturing systems.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and the Rest of Europe
  • Asia Pacific: India, Thailand, Australia & New Zealand, Japan, South Korea, China, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific is set to be the fastest-growing region by 2028.
    • The Asia Pacific’s rising investment in the pharmaceutical and biopharmaceutical industry and the growing contract research organization (CRO) and contract manufacturing organization (CMO), primarily drive the market growth.
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global pharmaceutical continuous manufacturing market are: 

  • Eli Lilly and Company
  • Korsch AG
  • Pfizer Inc
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc
  • Others

Key strategies adopted by some of these companies:

In December 2020, Eli Lilly and Company and Boehringer Ingelheim announced that the Food and Drug Administration (FDA) had acknowledged a supplementary New Drug Application for Jardiance. Moreover, it is also investigated as a potential new treatment to reduce the risk of cardiovascular demise and hospitalization for heart failure.

Key findings of the global pharmaceutical continuous manufacturing market:

  • The developing pharmaceutical market plays an essential role in fueling market growth.
  • Pharmaceutical companies is the leading end-user.
  • The API manufacturing segment, under the application category, is set to grow with the highest CAGR.
  • Pharmaceutical enterprises establish partnerships with local manufacturers, business partners, packaging companies, and distributors, in order to establish a stronger presence across various consumer preferences.

 

Frequently Asked Questions and Answers (FAQs):

  • What is the impact of COVID-19 on the global pharmaceutical continuous manufacturing market?

A: The pharmaceutical continuous manufacturing market has been significantly affected due to the novel coronavirus outbreak, since the supply of raw materials and active pharmaceutical ingredients have stalled. As a result, the non-availability or disrupted supply of raw materials and packing materials hinders the market growth.

  • What is the role of emerging economies in the development of the global pharmaceutical continuous manufacturing market?

A: The healthcare industry in emerging economies is developing at a significant rate, owing to the growing demand for advanced manufacturing systems. This aspect has considerably impacted the market growth.

  • How have the rising government initiatives impacted the pharmaceutical continuous manufacturing market?

A: The rising initiatives taken by regulatory authorities, such as the United States Food and Drug Administration (FDA), encourages pharmaceutical organizations to implement continuous manufacturing concepts and offers accelerated approval processes, thereby boosting the pharmaceutical continuous manufacturing market growth.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    •    KEY DRIVERS
      • DEVELOPMENT OPPORTUNITIES IN UNTAPPED EMERGING MARKETS
      • INCREASED ADOPTION OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
      • RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING SYSTEMS
      • RISE IN PRODUCTION OF LARGE MOLECULES AND BIOLOGICS
      • INCREASE IN THE HEALTHCARE EXPENDITURE
    •    KEY RESTRAINTS
      • INCREASING CUSTOMER ANTICIPATIONS
      • LACK OF DEMAND FOR CONTINUOUS MANUFACTURING SYSTEMS IN UNDERDEVELOPED COUNTRIES
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY PRODUCT
    • INTEGRATED CONTINUOUS SYSTEM
    • SEMI-CONTINUOUS SYSTEM
    • CONTROL & SOFTWARE
  3. MARKET BY APPLICATION
    • FINAL DRUG PRODUCT MANUFACTURING
    • API MANUFACTURING
  4. MARKET BY END-USER
    • PHARMACEUTICAL COMPANIES
    • CONTRACT MANUFACTURING ORGANIZATIONS
    • OTHER END-USERS
  5. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •     EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •     ASIA PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • INDIA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA PACIFIC
    •     REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLER
      • KEY CHALLENGE
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    •    KEY STRATEGIC DEVELOPMENTS
      • MERGER & ACQUISITIONS
      • PRODUCT LAUNCH & DEVELOPMENTS
      • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    •    COMPANY PROFILE
      • COPERION GMBH
      • ELI LILLY & COMPANY
      • GEA GROUP AG
      • GEBRUDER LODIGE MASCHINENBAU GMBH
      • GLATT GMBH
      • HOSOKAWA MICRON CORPORATION
      • KORSCH AG
      • LB BOHLE MASCHINEN + VERFAHREN GMBH
      • MUNSON MACHINERY COMPANY
      • PFIZER INC
      • SIEMENS HEALTHINEERS
      • SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
      • THERMO FISHER SCIENTIFIC INC

TABLE LIST

TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL CONTINUOUS MANUFACTURING

TABLE 2: PROJECTED NATIONAL HEALTHCARE EXPENDITURE, 2021-2028 (IN $ BILLION)

TABLE 3: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 4: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 5: GLOBAL INTEGRATED CONTINUOUS SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 6: GLOBAL INTEGRATED CONTINUOUS SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL SEMI-CONTINUOUS SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 8: GLOBAL SEMI-CONTINUOUS SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL CONTROL & SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 10: GLOBAL CONTROL & SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 11: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 12: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 13: GLOBAL FINAL DRUG PRODUCT MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 14: GLOBAL FINAL DRUG PRODUCT MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 15: GLOBAL API MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 16: GLOBAL API MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 18: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 19: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 20: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 21: GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 22: GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 23: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 26: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 27: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 28: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 29: LEADING PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

TABLE 30: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: LEADING PLAYERS OPERATING IN EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

TABLE 33: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 34: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 35: LEADING PLAYERS OPERATING IN ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

TABLE 36: REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: LEADING PLAYERS OPERATING IN REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

FIGURE LIST          

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, IN 2020

FIGURE 6: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, IN 2020

FIGURE 10: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, IN 2020

FIGURE 13: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 17: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 18: CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 21: FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 22: UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 23: ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: BELGIUM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: REST OF EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: REST OF ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 39: LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • INTEGRATED CONTINUOUS SYSTEM
    • SEMI-CONTINUOUS SYSTEM
    • CONTROL & SOFTWARE
  2. MARKET BY APPLICATION
    • FINAL DRUG PRODUCT MANUFACTURING
    • API MANUFACTURING
  3. MARKET BY END-USER
    • PHARMACEUTICAL COMPANIES
    • CONTRACT MANUFACTURING ORGANIZATIONS
    • OTHER END-USERS
  4. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •     EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    •     ASIA PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • INDIA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA PACIFIC
    •     REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLER
      • KEY CHALLENGE
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now